Toggle navigation
Home
Search
Services
Blog
Contact
About
Breath-Activated Device for Delivery of Aerosols
Ackerman, Bernard
Ackrad Laboratories, Inc., Cranford, NJ, United States
Search grants from Bernard Ackerman
Search grants from Ackrad Laboratories, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Oregon Environmental Pub Hlth Tracking Network Implementation Phase 3: Maintenance and Enhancement
Regulation of Wnt signal transduction by flavonoids.
MBRS RISE Program at Albany State University
Molecular Pharm. and Biochem. of Novel Dual Speciificity Phosphatase Inhibitors
Regulation and Mechanism of Cell Surface Synthesis
Recently added grants:
Response of the Gut Microbiome and Circulating Metabolome to Diet Intervention in Young Children: Ancillary Study to the Keeping Ideal Cardiovascular Health Family Intervention Trial (KIDFIT)
The role of MAP3K2/3 in modulating neutrophil ROS release and its translational potential
The role of the locus coeruleus in mediating pupil-linked arousal
Cell-Type Specific Regulation of Dendritic mRNA in the Hippocampus
Mechanistic Insights into m6A-Mediated Regulation of Brain Development
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Lung Diseases (NHLBI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43HR066027-002
Application #
3657420
Study Section
Project Start
1986-09-19
Project End
Budget Start
1987-06-18
Budget End
1987-06-18
Support Year
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Ackrad Laboratories, Inc.
Department
Type
DUNS #
City
Cranford
State
NJ
Country
United States
Zip Code
07016
Related projects
NIH 1987
N43 HR
Breath-Activated Device for Delivery of Aerosols
Ackerman, Bernard / Ackrad Laboratories, Inc.
NIH 1986
N43 HR
Breath-Activated Device for Delivery of Aerosols
Ackerman, Bernard / Ackrad Laboratories, Inc.
Comments
Be the first to comment on Bernard Ackerman's grant